As of Aug. 31, there were 806 cases and 30 probable cases of C. auris across the country. An additional 1642 patients were found to be colonized with C. auris, up from 1,540 as of July 31.
The cases are heavily concentrated in New York, which has reported 388 cases of the infection. Illinois and New Jersey follow New York, with 227 and 137 cases respectively. In all, 14 U.S. states have reported C. auris cases.
Multiple cases of C. auris have been reported globally, including in Australia, Canada, China, France, India and Japan.
C. auris, which can live on surfaces in healthcare environments, causes bloodstream, wound and ear infections. The infections tend to be resistant to antifungal drugs, making them hard to treat.
More articles on clinical leadership & infection control:
CDC pinpoints potential culprit for vaping illness
MD Anderson says patient CMS reported dead is still alive
Vaping damage is ‘evil I haven’t seen before,’ Henry Ford lung transplant surgeon says
